Gene Express, NeoGenomics Ink Licensing, Validation Agreements | GenomeWeb
NEW YORK (GenomeWeb News) – Gene Express said today that it has signed three agreements with NeoGenomics Laboratories covering licensing, commercialization, and FDA validation of its gene expression and reverse transcription PCR technologies.
 
Under the terms of the agreements, NeoGenomics will license Gene Express’s Standardized Expression Measurement Center, or SEM Center, and Standardized Reverse Transcription Polymerase Chain Reaction, or StarRT-PCR, technology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.